These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6131339)

  • 1. Is serum aluminium monitoring useful in evaluating aluminium intoxication?
    Gilli P; Malacarne F; Fagioli F
    Lancet; 1983 Mar; 1(8325):656. PubMed ID: 6131339
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminium hydroxide versus sucralfate as a phosphate binder in uraemia.
    Leung AC; Henderson IS; Halls DJ; Dobbie JW
    Br Med J (Clin Res Ed); 1983 Apr; 286(6375):1379-81. PubMed ID: 6404468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnesium hydroxide treatment of hyperphosphatemia in chronic hemodialysis patients with an aluminum overload].
    Roujouleh H; Lavaud S; Toupance O; Melin JP; Chanard J
    Nephrologie; 1987; 8(2):45-50. PubMed ID: 3614505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1 alpha OH vitamin D3 increases plasma aluminium in haemodialysed patients taking Al (OH)3.
    Fournier A; Demontis R; Tahiri Y; Herve M; Moriniere P; Leflon A; Abdull-Massih Z; Atik H; Benelmouffok S
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():390-4. PubMed ID: 3991529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminium poisoning in uremic children].
    Hinojosa-Lezama M; Gordillo-Paniagua G
    Bol Med Hosp Infant Mex; 1986 Sep; 43(9):532-6. PubMed ID: 3790225
    [No Abstract]   [Full Text] [Related]  

  • 6. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia.
    O'Donovan R; Baldwin D; Hammer M; Moniz C; Parsons V
    Lancet; 1986 Apr; 1(8486):880-2. PubMed ID: 2870354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemic osteomalacia and encephalopathy due to aluminium intoxication in haemodialysis patients. Clinical aspects and treatment with desferrioxamine.
    Mudde AH; Roodvoets AP; Van Groningen K
    Neth J Med; 1985; 28(1):6-11. PubMed ID: 3974771
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aluminum poisoning by phosphate binders in kidney insufficiency].
    Fuchs C; Dorn D; Doht B; Freytag E; Fuchs CA; Henning HV; Scheler F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1313-5. PubMed ID: 611842
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG; Nielsen LP
    Miner Electrolyte Metab; 1984; 10(6):345-50. PubMed ID: 6503890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking Al(OH)3.
    Demontis R; Westeel PF; Boudalliez B; Moriniere P; Leflon A; Abdulmassih Z; Atik H; Renaud H; Fournier A
    Kidney Int Suppl; 1988 Mar; 24():S175-7. PubMed ID: 3163043
    [No Abstract]   [Full Text] [Related]  

  • 11. Aluminium toxicity during regular haemodialysis.
    Elliott HL; Dryburgh F; Fell GS; Sabet S; Macdougall AI
    Br Med J; 1978 Apr; 1(6120):1101-3. PubMed ID: 638617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of aluminium intoxication: a new scheme for desferrioxamine administration.
    Douthat WG; Acuña Aguerre G; Fernández Martín JL; Mouzo R; Cannata Andía JB
    Nephrol Dial Transplant; 1994; 9(10):1431-4. PubMed ID: 7816256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium carbonate: a suitable alternative to aluminum hydroxide as phosphate binder.
    Malberti F; Surian M; Colussi G; Poggio F; Minoia C; Salvadeo A
    Kidney Int Suppl; 1988 Mar; 24():S184-5. PubMed ID: 3163047
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis.
    Andreoli SP; Bergstein JM; Sherrard DJ
    N Engl J Med; 1984 Apr; 310(17):1079-84. PubMed ID: 6708989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle bone disease in Hong Kong: a study of aluminum associated osteomalacia.
    Chan MK; Varghese Z; Li MK; Wong WS; Li CS
    Int J Artif Organs; 1990 Mar; 13(3):162-8. PubMed ID: 2189835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis.
    Morinière P; Fournier A; Leflon A; Hervé M; Sebert JL; Grégoire I; Bataille P; Guéris J
    Nephron; 1985; 39(4):309-15. PubMed ID: 3982576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A
    Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum aluminum levels in dialysis dementia.
    McKinney TD; Basinger M; Dawson E; Jones MM
    Nephron; 1982; 32(1):53-6. PubMed ID: 7177277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease.
    Salusky IB; Foley J; Nelson P; Goodman WG
    N Engl J Med; 1991 Feb; 324(8):527-31. PubMed ID: 1992306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cela n'arrive qu'aux autres (aluminium intoxication only happens in the other nephrologist's dialysis centre).
    Simoes J; Barata JD; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):67-8. PubMed ID: 8177479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.